The health risks related to hormone therapy with estrogen, aimed at treating menopause symptoms, might go away in women in their 50s after they stop the treatments, according to a study.
Research focusing on more than 7,000 women showed that while both stroke and blood clots increased during treatment with estrogen, there was no significant difference in health risks after 10 years between those who took hormones for treatment and those who hadn’t, said the study published in the Journal of the American Medical Association.
“But that doesn’t mean continuing to take them for five to 10 years won’t have some health risks emerge,” said Graham Colditz, at the Washington University School of Medicine, who wrote an editorial published with the study.
INITIATIVE
The study centered on some of the women who had also participated in the US -government-funded Women’s Health Initiative (WHI), the study that first raised concerns about the safety of hormone therapy.
In 2004, data from the WHI showed that taking estrogen by itself increased women’s risk of stroke and didn’t reduce their risk of coronary heart disease.
The 7,645 women in the study had all undergone hysterectomies before joining the WHI, and were assigned to a group that received estrogen pills. They were followed for 10 years — six of estrogen treatment with Premarin, and four years after ending the treatment.
During the treatment, those in the estrogen group were 36 percent more likely to have a stroke and 47 percent more likely to experience blood clots than the group that took placebos.
However, after 10 years, there was no significant difference between the groups in these conditions.
For women in their 50s, estrogen treatment even appeared to have some benefits over time, being linked to a 46 percent drop in the risk of a heart attack and a 27 percent drop in the risk of dying over 10 years.
LIMITED BENEFIT
Women in their 70s, though, did not get the same benefits, and for some conditions their risks rose if they took estrogen.
“If you’re a woman in your 70s, there’s very little reason to initiate estrogen,” said Andrea LaCroix for the Fred Hutchinson Cancer Research Center in Seattle and the lead author of the study.
The risk of breast cancer in this study appeared to be the same between women who took estrogen and those who didn’t, though other studies have found a link between breast cancer and hormone therapy.
Chinese President Xi Jinping (習近平) is to visit Russia next month for a summit of the BRICS bloc of developing economies, Chinese Minister of Foreign Affairs Wang Yi (王毅) said on Thursday, a move that comes as Moscow and Beijing seek to counter the West’s global influence. Xi’s visit to Russia would be his second since the Kremlin sent troops into Ukraine in February 2022. China claims to take a neutral position in the conflict, but it has backed the Kremlin’s contentions that Russia’s action was provoked by the West, and it continues to supply key components needed by Moscow for
Japan scrambled fighter jets after Russian aircraft flew around the archipelago for the first time in five years, Tokyo said yesterday. From Thursday morning to afternoon, the Russian Tu-142 aircraft flew from the sea between Japan and South Korea toward the southern Okinawa region, the Japanese Ministry of Defense said in a statement. They then traveled north over the Pacific Ocean and finished their journey off the northern island of Hokkaido, it added. The planes did not enter Japanese airspace, but flew over an area subject to a territorial dispute between Japan and Russia, a ministry official said. “In response, we mobilized Air Self-Defense
CRITICISM: ‘One has to choose the lesser of two evils,’ Pope Francis said, as he criticized Trump’s anti-immigrant policies and Harris’ pro-choice position Pope Francis on Friday accused both former US president Donald Trump and US Vice President Kamala Harris of being “against life” as he returned to Rome from a 12-day tour of the Asia-Pacific region. The 87-year-old pontiff’s comments on the US presidential hopefuls came as he defied health concerns to connect with believers from the jungle of Papua New Guinea to the skyscrapers of Singapore. It was Francis’ longest trip in duration and distance since becoming head of the world’s nearly 1.4 billion Roman Catholics more than 11 years ago. Despite the marathon visit, he held a long and spirited
The pitch is a classic: A young celebrity with no climbing experience spends a year in hard training and scales Mount Everest, succeeding against some — if not all — odds. French YouTuber Ines Benazzouz, known as Inoxtag, brought the story to life with a two-hour-plus documentary about his year preparing for the ultimate challenge. The film, titled Kaizen, proved a smash hit on its release last weekend. Young fans queued around the block to get into a preview screening in Paris, with Inoxtag’s management on Monday saying the film had smashed the box office record for a special cinema